Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotide

Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotide

US Patent 10533038 · Granted Jan 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotro2025
Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotro2025
Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotro2025
Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF12022
Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF12022
Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF12022
Ice-cleaved alpha-synuclein as a biomarker2015
Compositions and methods for the diagnosis, treatment, and prevention of amyotro2013